Developing a potent vaccine against : critical considerations and challenges.
1/5 보강
( is closely associated with gastric cancer and peptic ulcers.
APA
Hasanzadeh Haghighi F, Menbari S, et al. (2024). Developing a potent vaccine against : critical considerations and challenges.. Expert reviews in molecular medicine, 27, e12. https://doi.org/10.1017/erm.2024.19
MLA
Hasanzadeh Haghighi F, et al.. "Developing a potent vaccine against : critical considerations and challenges.." Expert reviews in molecular medicine, vol. 27, 2024, pp. e12.
PMID
39584502 ↗
Abstract 한글 요약
( is closely associated with gastric cancer and peptic ulcers. The effectiveness of antibiotic treatment against is diminished by the emergence of drug-resistant strains, side effects, high cost and reinfections. Given the circumstances, it is imperative to develop a potent vaccination targeting Understanding 's pathogenicity and the host's immune response is essential to developing a vaccine. Furthermore, vaccine evaluation necessitates the careful selection of design formulation. This review article aims to provide a concise overview of the considerations involved in selecting the optimal antigen, adjuvant, vaccine delivery system and laboratory animal model for vaccine formulation. Furthermore, we will discuss some significant obstacles in the realm of developing a potent vaccination against
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.